Axa
VRTX icon

Axa’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$76.2M Buy
171,270
+10,477
+7% +$4.66M 0.22% 101
2025
Q1
$78M Buy
160,793
+20,003
+14% +$9.7M 0.26% 77
2024
Q4
$56.7M Sell
140,790
-3,620
-3% -$1.46M 0.17% 117
2024
Q3
$67.2M Sell
144,410
-48,927
-25% -$22.8M 0.2% 108
2024
Q2
$90.6M Sell
193,337
-36,554
-16% -$17.1M 0.27% 77
2024
Q1
$96.1M Sell
229,891
-43,470
-16% -$18.2M 0.29% 74
2023
Q4
$111M Sell
273,361
-12,314
-4% -$5.01M 0.36% 62
2023
Q3
$99.3M Buy
285,675
+10,329
+4% +$3.59M 0.35% 66
2023
Q2
$96.9M Sell
275,346
-28,607
-9% -$10.1M 0.32% 72
2023
Q1
$95.8M Sell
303,953
-39,737
-12% -$12.5M 0.33% 74
2022
Q4
$99.3M Buy
343,690
+66,193
+24% +$19.1M 0.36% 66
2022
Q3
$80.3M Buy
277,497
+43,581
+19% +$12.6M 0.32% 76
2022
Q2
$65.9M Sell
233,916
-73,703
-24% -$20.8M 0.24% 103
2022
Q1
$80.3M Sell
307,619
-98,580
-24% -$25.7M 0.23% 103
2021
Q4
$89.2M Sell
406,199
-15,690
-4% -$3.45M 0.23% 106
2021
Q3
$76.5M Buy
421,889
+198,955
+89% +$36.1M 0.21% 114
2021
Q2
$45M Sell
222,934
-11,825
-5% -$2.38M 0.13% 186
2021
Q1
$50.4M Sell
234,759
-74,326
-24% -$16M 0.15% 158
2020
Q4
$73M Sell
309,085
-30,879
-9% -$7.3M 0.23% 109
2020
Q3
$92.5M Sell
339,964
-131,440
-28% -$35.8M 0.33% 62
2020
Q2
$137M Buy
471,404
+46,653
+11% +$13.5M 0.54% 32
2020
Q1
$101M Buy
424,751
+25,645
+6% +$6.1M 0.51% 38
2019
Q4
$87.4M Buy
399,106
+108,147
+37% +$23.7M 0.36% 64
2019
Q3
$49.3M Sell
290,959
-169,430
-37% -$28.7M 0.2% 135
2019
Q2
$84.4M Sell
460,389
-76,979
-14% -$14.1M 0.33% 73
2019
Q1
$98.8M Sell
537,368
-15,291
-3% -$2.81M 0.39% 54
2018
Q4
$91.6M Buy
552,659
+20,083
+4% +$3.33M 0.4% 56
2018
Q3
$103M Sell
532,576
-271,505
-34% -$52.3M 0.38% 60
2018
Q2
$137M Buy
804,081
+114,996
+17% +$19.5M 0.52% 37
2018
Q1
$112M Buy
689,085
+426,971
+163% +$69.6M 0.45% 52
2017
Q4
$39.3M Sell
262,114
-12,084
-4% -$1.81M 0.15% 185
2017
Q3
$41.7M Buy
274,198
+103,149
+60% +$15.7M 0.18% 171
2017
Q2
$22M Sell
171,049
-5,880
-3% -$758K 0.1% 243
2017
Q1
$19.3M Sell
176,929
-325,859
-65% -$35.6M 0.09% 269
2016
Q4
$37M Sell
502,788
-64,804
-11% -$4.77M 0.17% 164
2016
Q3
$49.5M Sell
567,592
-62,583
-10% -$5.46M 0.22% 142
2016
Q2
$54.2M Buy
630,175
+64,659
+11% +$5.56M 0.24% 120
2016
Q1
$45M Sell
565,516
-59,822
-10% -$4.76M 0.2% 147
2015
Q4
$78.7M Buy
625,338
+19,985
+3% +$2.51M 0.34% 67
2015
Q3
$63M Buy
605,353
+80,402
+15% +$8.37M 0.26% 104
2015
Q2
$64.8M Sell
524,951
-3,342
-0.6% -$413K 0.26% 111
2015
Q1
$62.3M Buy
528,293
+59,444
+13% +$7.01M 0.26% 111
2014
Q4
$55.7M Buy
468,849
+102,747
+28% +$12.2M 0.22% 137
2014
Q3
$41.1M Buy
366,102
+7,747
+2% +$870K 0.18% 163
2014
Q2
$33.9M Buy
358,355
+116,167
+48% +$11M 0.14% 189
2014
Q1
$17.1M Buy
242,188
+12,613
+5% +$892K 0.07% 279
2013
Q4
$17.1M Buy
229,575
+25,616
+13% +$1.9M 0.08% 274
2013
Q3
$15.5M Buy
203,959
+37,862
+23% +$2.87M 0.08% 274
2013
Q2
$13.3M Buy
+166,097
New +$13.3M 0.07% 280